TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Corum Group Limited ( (AU:PHX) ) has shared an announcement.
Pharmx Technologies has renewed its National Diabetes Services Scheme (NDSS) agreement, reinforcing its role as a crucial digital infrastructure in Australia’s healthcare supply chain. This renewal underscores Pharmx’s commitment to national health service delivery and strengthens its position in pharmacy operations. Additionally, Pharmx has expanded its supplier network by partnering with over 50 new suppliers across Australia and New Zealand, enhancing platform utility and improving pharmacy engagement. This strategic expansion is set to increase transaction volume and order frequency, solidifying Pharmx’s leadership as the most connected pharmacy ordering network in the region.
More about Corum Group Limited
Pharmx Technologies Ltd. is a leading pharmacy ordering platform in Australia and New Zealand, providing essential technology infrastructure for seamless ordering and inventory management. It connects a vast network of pharmacies, suppliers, and technology vendors, facilitating approximately $20 billion in transactions annually. Pharmx is positioned for sustained growth driven by population growth, demographic shifts, and regulatory changes, leveraging its extensive network and advanced data capabilities to enhance healthcare outcomes.
Average Trading Volume: 678,563
Technical Sentiment Signal: Buy
Current Market Cap: A$55.06M
See more data about PHX stock on TipRanks’ Stock Analysis page.